Back to search

University of Glasgow

Immune regulation in multiple myeloma: the host-tumour conflict

Abstract

dc:description.abstract

The data presented in this thesis demonstrates that the malignant plasma cells of multiple myeloma are capable of suppressing the activation of T lymphocytes. The myeloma cells prevent activation of T cells from healthy donors by allo-antigen, mitogen and IL-2, mediated by the production of soluble, immuno-suppressive factor. This factor was responsible for inducing cell cycle arrest and failure of the T cells to progress into the autocrine IL-2 autocrine pathway, which is of critical importance in the activation of T cells. To further investigate this interaction an in vitro model system was developed to examine the key stages of T cell activation and homeostasis. Myeloma cells constitutively expressed high levels of TGF-1 mRNA transcripts as detected by RT-PCR which were translated into latent protein and secreted as detected by immunohistochemistry and ELSIA, respectively. The reversal of the immuno-suppression induced by the myeloma cells using the specific TGF-1 antagonist, Latency Associated Peptide, confirmed that TGF-1 is a major factor in myeloma-associated suppression of T lymphocyte activation. It was demonstrated that the myeloma cells prevent the T cells, upon activation, from up-regulating the surface expression of the -chain of the IL-2R thus preventing the formation of the high-affinity receptor. The reduced expression of IL-2R resulted from altered transcription of the -chain gene in response to re-stimulation of primary T cells with IL-2. When signalling events in primary T cells responding to re-stimulation with Il-2 was examined, myeloma cells inhibited the phosphorylation of both STAT3 and STAT5. However, using a novel IL-2-dependnet T cell line (IDBL), which does not require the expression of the high affinity IL-2R for its responses to IL-2, it was shown that these cells are insensitive to the myeloma-derived TGF-, in terms of DNA synthesis and proliferation, despite demonstrating failure of phosphorylation of STAT5. It was demonstrated that phosphorylation of STAT3 was unchanged when IDBL cells were co-cultured with myeloma cell lines.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2000

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cook, Gordon

Subjects

dc:subject × 2

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Cook, Gordon. Immune regulation in multiple myeloma: the host-tumour conflict. PhD thesis, University of Glasgow, 2000.